Home

IP115-16 (unrestricted)

released
No limitations
Certificate Identifier
IP115-16
Original Documents
https://drive.google.com/file/d/1Kq_XPlsXOuKhDiPRHj-FJi-fNTH1LG7X/view?usp=drive_link
Creation Timestamp
October 24, 2024
Release Timestamp
February 11, 2025
Submitted By
Jennifer Jou
Attribution
Ansuman Satpathy, Stanford

Samples

18 items
Sample Terms
Summary
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 3 μM Yoda1 for 4 hours
InVitroSystem
Homo sapiens HUDEP-2 differentiated cell specimen induced to erythrocyte for 14 days
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 10 ng/mL tumor necrosis factor alpha for 4 hours
InVitroSystem
Homo sapiens (female) TeloHAEC cell line
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 10 ng/mL tumor necrosis factor alpha for 1 day
InVitroSystem
Homo sapiens HUDEP-2 differentiated cell specimen induced to erythrocyte for 7 days
InVitroSystem
Homo sapiens (female) TeloHAEC cell line
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 10 ng/mL tumor necrosis factor alpha for 1 day
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 3 μM Yoda1 for 4 hours
InVitroSystem
Homo sapiens (female) TeloHAEC cell line treated with 10 ng/mL tumor necrosis factor alpha for 4 hours